Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubiquinol in Prediabetic Patients (Thailand)
TCTR20250416004Phase 4
Key facts
- Status
- Completed
- Start
- Jun 2024
- Countries
- 1
- Sponsor
- College of Integrative Medicine, Dhurakij Pundit University
- Modality
- Small Molecules
- Drugs
- coenzyme q10
- Conditions
- prediabetes
01
Overview
Phase 4, randomised, double-blind trial in prediabetes comparing Ubiquinol with Placebo (2 arms). Started Jun 2024; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Ubiquinol
Participants receive ubiquinol supplementation.
Placebo
Participants receive matching placebo.
03
Who it enrols
Adults with prediabetes; detailed inclusion and exclusion criteria are not provided in the registry entry.
Beyond the preview
Go deeper on TCTR20250416004.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250416004.